Polar Asset Management Partners Inc. Eli Lilly & CO Transaction History

Polar Asset Management Partners Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $1.3 Million - $1.64 Million	1,800 Added 257.14%	2,500 $2.26 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $414,540 - $554,596	700 New	700 $544,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $7.04 Million - $9.71 Million	-16,200 Reduced 87.57%	2,300 $1.24 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.19 Million - $1.59 Million	-3,400 Reduced 15.53%	18,500 $8.68 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $3.39 Million - $3.98 Million	-10,900 Reduced 33.23%	21,900 $7.52 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $9.14 Million - $10.7 Million	32,800 New	32,800 $10.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $221,895 - $287,020	-1,229 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $201,949 - $261,432	1,229 New	1,229 $230,000

4,009

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $773B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.